Search results
Results From The WOW.Com Content Network
Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%. According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
This is a list of open-access journals by field. The list contains notable journals which have a policy of full open access. It does not include delayed open access journals, hybrid open access journals, or related collections or indexing services.
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
A journal's SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige.
Notwithstanding the substantial cleanup, the number of journals included in DOAJ has continued to grow, to reach 14,299 as of 3 March 2020. [7] As of December 2022, [update] the independent database contains more than 18,650 open access journals and 8,265,272 articles covering all areas of science, technology, medicine, social sciences and the ...
Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents.It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. [1]
The values for Nature journals lie well above the expected ca. 1:1 linear dependence because those journals contain a significant fraction of editorials. CiteScore was designed to compete with the two-year JCR impact factor, which is currently the most widely used journal metric. [7] [8] Their main differences are as follows: [9]